BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38135017)

  • 21. A global survey on the utilization of cryotherapy and compression therapy for the prevention of chemotherapy-induced peripheral neuropathy.
    Chan A; Elsayed A; Ng DQ; Ruddy K; Loprinzi C; Lustberg M
    Support Care Cancer; 2022 Dec; 30(12):10001-10007. PubMed ID: 36214880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Siriraj, in-house-developed, frozen gloves for cold therapy reduction of chemotherapy-induced peripheral neuropathy in gynecological cancer patients: randomized controlled trial.
    Chitkumarn P; Rahong T; Achariyapota V
    Support Care Cancer; 2022 Jun; 30(6):4835-4843. PubMed ID: 35147758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of gabapentin for the prevention of paclitaxel induced peripheral neuropathy: A randomized placebo controlled clinical trial.
    Aghili M; Zare M; Mousavi N; Ghalehtaki R; Sotoudeh S; Kalaghchi B; Akrami S; Esmati E
    Breast J; 2019 Mar; 25(2):226-231. PubMed ID: 30773731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial).
    Joy L; Jolien R; Marithé C; Stijn E; Laura S; Hilde L; Sandra B; Wendy N; Ruth H; Liesbeth R; Sylvana S; Sylvia H; Jeroen M
    Support Care Cancer; 2022 Jun; 30(6):5509-5517. PubMed ID: 35312857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance).
    Sharma MR; Mehrotra S; Gray E; Wu K; Barry WT; Hudis C; Winer EP; Lyss AP; Toppmeyer DL; Moreno-Aspitia A; Lad TE; Velasco M; Overmoyer B; Rugo HS; Ratain MJ; Gobburu JV
    J Clin Pharmacol; 2020 Apr; 60(4):444-452. PubMed ID: 31802506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial.
    Ghoreishi Z; Esfahani A; Djazayeri A; Djalali M; Golestan B; Ayromlou H; Hashemzade S; Asghari Jafarabadi M; Montazeri V; Keshavarz SA; Darabi M
    BMC Cancer; 2012 Aug; 12():355. PubMed ID: 22894640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy.
    Khan Z; Jung M; Crow M; Mohindra R; Maiya V; Kaminker JS; Hackos DH; Chandler GS; McCarthy MI; Bhangale T
    Genome Med; 2023 Jun; 15(1):45. PubMed ID: 37344884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy-induced peripheral neuropathy and neuropathic pain].
    Schuler U; Heller S
    Schmerz; 2017 Aug; 31(4):413-425. PubMed ID: 28293734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer.
    Coolbrandt A; Vancoille K; Dejaeger E; Peeters H; Laenen A; Neven P; Punie K; Wildiers H
    Breast Cancer Res Treat; 2022 Apr; 192(2):293-301. PubMed ID: 34982322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel.
    Pandey P; Kumar A; Pushpam D; Khurana S; Malik PS; Gogia A; Arunmozhimaran E; Singh MB; Chandran DS; Batra A
    Trials; 2023 Feb; 24(1):79. PubMed ID: 36732774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study.
    Leal AD; Qin R; Atherton PJ; Haluska P; Behrens RJ; Tiber CH; Watanaboonyakhet P; Weiss M; Adams PT; Dockter TJ; Loprinzi CL;
    Cancer; 2014 Jun; 120(12):1890-7. PubMed ID: 24619793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors.
    Kober KM; Olshen A; Conley YP; Schumacher M; Topp K; Smoot B; Mazor M; Chesney M; Hammer M; Paul SM; Levine JD; Miaskowski C
    Mol Pain; 2018; 14():1744806918816462. PubMed ID: 30426838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).
    Mongiovi JM; Zirpoli GR; Cannioto R; Sucheston-Campbell LE; Hershman DL; Unger JM; Moore HCF; Stewart JA; Isaacs C; Hobday TJ; Salim M; Hortobagyi GN; Gralow JR; Thomas Budd G; Albain KS; Ambrosone CB; McCann SE
    Breast Cancer Res; 2018 Nov; 20(1):146. PubMed ID: 30486865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of the development of nab-paclitaxel-induced peripheral neuropathy in breast cancer patients: post hoc analysis of a prospective, phase II, self-controlled clinical trial.
    Kanbayashi Y; Sakaguchi K; Ishikawa T; Tabuchi Y; Takagi R; Yokota I; Katoh N; Takayama K; Taguchi T
    Med Oncol; 2022 Jul; 39(10):153. PubMed ID: 35852641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryocompression to Reduce Peripheral Neuropathy in Gynecologic Cancer: A Randomized Controlled Trial.
    Anastasio MK; Unnithan S; Scott A; Hayes T; Shah S; Moss HA; Erkanli A; Havrilesky LJ
    Obstet Gynecol; 2023 Dec; 142(6):1459-1467. PubMed ID: 37883997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study.
    Salgado TM; Quinn CS; Krumbach EK; Wenceslao I; Gonzalez M; Reed HL; Syverson JG; Etz RS; Vangipuram K; Barker MR; Henry NL; Farris KB; Hertz DL
    Support Care Cancer; 2020 Sep; 28(9):4163-4172. PubMed ID: 31897779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.
    Chan YN; Jheng YW; Wang PJ; Chen CY; Lin MW; Wang YJ
    Clin J Oncol Nurs; 2019 Oct; 23(5):494-501. PubMed ID: 31538967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy-induced peripheral neuropathy among patients with ovarian cancer.
    Jin L; Zhang Y; Yang W
    Int J Gynaecol Obstet; 2020 Jun; 149(3):303-308. PubMed ID: 32133643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuromuscular ultrasound for taxane peripheral neuropathy in breast cancer.
    Lycan TW; Hsu FC; Ahn CS; Thomas A; Walker FO; Sangueza OP; Shiozawa Y; Park SH; Peters CM; Romero-Sandoval EA; Melin SA; Sorscher S; Ansley K; Lesser GJ; Cartwright MS; Strowd RE
    Muscle Nerve; 2020 May; 61(5):587-594. PubMed ID: 32052458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.